

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.42609208 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.42609208 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.22972851 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.22972851 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.66708336 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22110541 |
| 7 | kynurenine metabolic process (GO:0070189) | 6.04334342 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.02150047 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.02150047 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.02150047 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.87366560 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 5.85591801 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.70681324 |
| 14 | urea cycle (GO:0000050) | 5.68657633 |
| 15 | urea metabolic process (GO:0019627) | 5.68657633 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.64688285 |
| 17 | cysteine metabolic process (GO:0006534) | 5.61227009 |
| 18 | regulation of fibrinolysis (GO:0051917) | 5.53466118 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52587366 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51569504 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.45631151 |
| 22 | protein carboxylation (GO:0018214) | 5.45631151 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.44920371 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.41006549 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 5.37557359 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.34938617 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.20378689 |
| 28 | glycine metabolic process (GO:0006544) | 5.06212484 |
| 29 | regulation of complement activation (GO:0030449) | 5.06078626 |
| 30 | bile acid metabolic process (GO:0008206) | 5.02341569 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.95796437 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.87741898 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.79926629 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.76256995 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.67624974 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.67624974 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.67624974 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.67265106 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.67188154 |
| 40 | lysine catabolic process (GO:0006554) | 4.66270264 |
| 41 | lysine metabolic process (GO:0006553) | 4.66270264 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.65926831 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 4.64681532 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.64681532 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.63703463 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.62492102 |
| 47 | serine family amino acid metabolic process (GO:0009069) | 4.60718439 |
| 48 | triglyceride homeostasis (GO:0070328) | 4.58017663 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.58017663 |
| 50 | imidazole-containing compound metabolic process (GO:0052803) | 4.57435650 |
| 51 | serine family amino acid biosynthetic process (GO:0009070) | 4.54661341 |
| 52 | phospholipid efflux (GO:0033700) | 4.41986273 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.40125167 |
| 54 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.38265997 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.36876663 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.35396857 |
| 57 | glutamate metabolic process (GO:0006536) | 4.32520375 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.28437479 |
| 59 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.22554087 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.19081779 |
| 61 | cellular modified amino acid catabolic process (GO:0042219) | 4.18597017 |
| 62 | actin-myosin filament sliding (GO:0033275) | 4.16755990 |
| 63 | muscle filament sliding (GO:0030049) | 4.16755990 |
| 64 | cellular glucuronidation (GO:0052695) | 4.13574873 |
| 65 | ethanol oxidation (GO:0006069) | 4.12040580 |
| 66 | cholesterol efflux (GO:0033344) | 4.11594215 |
| 67 | fibrinolysis (GO:0042730) | 4.09611000 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.08828356 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.07897219 |
| 70 | amine catabolic process (GO:0009310) | 4.07897219 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 4.01058559 |
| 72 | nuclear pore complex assembly (GO:0051292) | 3.98892026 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.98763671 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 3.93004299 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.92301222 |
| 76 | arginine metabolic process (GO:0006525) | 3.87647507 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.87542028 |
| 78 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.83995576 |
| 79 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82071322 |
| 80 | response to muscle activity (GO:0014850) | 3.80248385 |
| 81 | drug catabolic process (GO:0042737) | 3.76478184 |
| 82 | cholesterol homeostasis (GO:0042632) | 3.76348199 |
| 83 | blood coagulation, intrinsic pathway (GO:0007597) | 3.75511304 |
| 84 | nuclear pore organization (GO:0006999) | 3.75440768 |
| 85 | skeletal muscle contraction (GO:0003009) | 3.74664361 |
| 86 | cofactor catabolic process (GO:0051187) | 3.73324455 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.72975979 |
| 88 | sterol homeostasis (GO:0055092) | 3.71310966 |
| 89 | complement activation (GO:0006956) | 3.69397668 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68694073 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 3.68596342 |
| 92 | organic acid catabolic process (GO:0016054) | 3.67127717 |
| 93 | carboxylic acid catabolic process (GO:0046395) | 3.67127717 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.67105008 |
| 95 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.66326764 |
| 96 | protein activation cascade (GO:0072376) | 3.64777575 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.63211237 |
| 98 | cytolysis (GO:0019835) | 3.62408280 |
| 99 | response to nitrosative stress (GO:0051409) | 3.61638900 |
| 100 | protein-lipid complex assembly (GO:0065005) | 3.59856056 |
| 101 | intestinal cholesterol absorption (GO:0030299) | 3.59391619 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.58884306 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.58884306 |
| 104 | actin-mediated cell contraction (GO:0070252) | 3.58677723 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58517102 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58517102 |
| 107 | L-serine metabolic process (GO:0006563) | 3.57865998 |
| 108 | heme transport (GO:0015886) | 3.56327463 |
| 109 | lipoprotein metabolic process (GO:0042157) | 3.55371534 |
| 110 | paraxial mesoderm development (GO:0048339) | 3.43773474 |
| 111 | carnitine shuttle (GO:0006853) | 3.39357361 |
| 112 | regulation of centriole replication (GO:0046599) | 3.28806555 |
| 113 | intestinal epithelial cell development (GO:0060576) | 3.15586847 |
| 114 | IMP metabolic process (GO:0046040) | 3.12930397 |
| 115 | sarcomere organization (GO:0045214) | 3.10101287 |
| 116 | mitotic sister chromatid cohesion (GO:0007064) | 3.07788078 |
| 117 | carnitine transmembrane transport (GO:1902603) | 3.07668420 |
| 118 | protein complex localization (GO:0031503) | 3.06708285 |
| 119 | cellular protein complex localization (GO:0034629) | 3.06327762 |
| 120 | mitotic metaphase plate congression (GO:0007080) | 3.04443793 |
| 121 | metaphase plate congression (GO:0051310) | 3.01229843 |
| 122 | glycogen catabolic process (GO:0005980) | 3.00269344 |
| 123 | mitotic chromosome condensation (GO:0007076) | 2.95926113 |
| 124 | biotin metabolic process (GO:0006768) | 2.93399075 |
| 125 | amino-acid betaine transport (GO:0015838) | 2.88500103 |
| 126 | carnitine transport (GO:0015879) | 2.88500103 |
| 127 | fatty acid transmembrane transport (GO:1902001) | 2.78861467 |
| 128 | striated muscle contraction (GO:0006941) | 2.78563357 |
| 129 | myofibril assembly (GO:0030239) | 2.73064367 |
| 130 | regulation of relaxation of muscle (GO:1901077) | 2.72415749 |
| 131 | creatine metabolic process (GO:0006600) | 2.71494941 |
| 132 | protein localization to kinetochore (GO:0034501) | 2.68120863 |
| 133 | pore complex assembly (GO:0046931) | 2.67189027 |
| 134 | glucan catabolic process (GO:0009251) | 2.66107004 |
| 135 | skeletal muscle adaptation (GO:0043501) | 2.65901094 |
| 136 | IMP biosynthetic process (GO:0006188) | 2.65565073 |
| 137 | regulation of RNA export from nucleus (GO:0046831) | 2.65350783 |
| 138 | gluconeogenesis (GO:0006094) | 2.64411229 |
| 139 | ribosome assembly (GO:0042255) | 2.63767343 |
| 140 | muscle cell cellular homeostasis (GO:0046716) | 2.60423281 |
| 141 | actin filament-based movement (GO:0030048) | 2.59831123 |
| 142 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.59597047 |
| 143 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.58160470 |
| 144 | glycogen biosynthetic process (GO:0005978) | 2.58105830 |
| 145 | glucan biosynthetic process (GO:0009250) | 2.58105830 |
| 146 | NADH metabolic process (GO:0006734) | 2.57987142 |
| 147 | fructose metabolic process (GO:0006000) | 2.54177060 |
| 148 | regulation of skeletal muscle contraction (GO:0014819) | 2.54120588 |
| 149 | cellular polysaccharide catabolic process (GO:0044247) | 2.53769239 |
| 150 | hexose biosynthetic process (GO:0019319) | 2.53376559 |
| 151 | actomyosin structure organization (GO:0031032) | 2.51887088 |
| 152 | intracellular lipid transport (GO:0032365) | 2.51626993 |
| 153 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.46961275 |
| 154 | protein localization to chromosome, centromeric region (GO:0071459) | 2.46628548 |
| 155 | peptidyl-lysine dimethylation (GO:0018027) | 2.46301550 |
| 156 | cardiac myofibril assembly (GO:0055003) | 2.46175699 |
| 157 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.45245303 |
| 158 | low-density lipoprotein particle clearance (GO:0034383) | 2.39117894 |
| 159 | quaternary ammonium group transport (GO:0015697) | 2.38629899 |
| 160 | establishment of chromosome localization (GO:0051303) | 2.36682335 |
| 161 | oxaloacetate metabolic process (GO:0006107) | 2.34952709 |
| 162 | kinetochore organization (GO:0051383) | 2.32883582 |
| 163 | aspartate family amino acid catabolic process (GO:0009068) | 2.31418925 |
| 164 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.30091583 |
| 165 | tricarboxylic acid cycle (GO:0006099) | 2.29461037 |
| 166 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.28488130 |
| 167 | positive regulation of chromosome segregation (GO:0051984) | 2.28314932 |
| 168 | COPII vesicle coating (GO:0048208) | 2.27928140 |
| 169 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.26657882 |
| 170 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.26657882 |
| 171 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.26657882 |
| 172 | positive regulation of hormone metabolic process (GO:0032352) | 2.26164158 |
| 173 | polysaccharide catabolic process (GO:0000272) | 2.24751974 |
| 174 | mitotic G2/M transition checkpoint (GO:0044818) | 2.23824761 |
| 175 | monosaccharide biosynthetic process (GO:0046364) | 2.23388245 |
| 176 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.23221759 |
| 177 | fatty acid homeostasis (GO:0055089) | 2.22037806 |
| 178 | cardiac muscle cell development (GO:0055013) | 2.21985382 |
| 179 | kinetochore assembly (GO:0051382) | 2.21402344 |
| 180 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.21196250 |
| 181 | muscle atrophy (GO:0014889) | 2.19786781 |
| 182 | positive regulation of catenin import into nucleus (GO:0035413) | 2.19567032 |
| 183 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.19423816 |
| 184 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.18905065 |
| 185 | regulation of centrosome cycle (GO:0046605) | 2.18575918 |
| 186 | desmosome organization (GO:0002934) | 2.16622427 |
| 187 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.16195879 |
| 188 | glycogen metabolic process (GO:0005977) | 2.15447426 |
| 189 | gap junction assembly (GO:0016264) | 2.13015142 |
| 190 | response to inactivity (GO:0014854) | 2.11642631 |
| 191 | CENP-A containing nucleosome assembly (GO:0034080) | 2.11455740 |
| 192 | cardiac muscle contraction (GO:0060048) | 2.11335195 |
| 193 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.10937677 |
| 194 | DNA unwinding involved in DNA replication (GO:0006268) | 2.10857971 |
| 195 | adult heart development (GO:0007512) | 2.09270568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.98847249 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98244488 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.54094427 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14508355 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.08509266 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.94646721 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.81392213 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.50795707 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.94595676 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.77674657 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.51288402 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.40492546 |
| 13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.85387335 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.80800941 |
| 15 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.63869400 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.39450453 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.32391698 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.13091350 |
| 19 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.05884734 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.04572486 |
| 21 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03247551 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.01354501 |
| 23 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5157470 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99414033 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.98083938 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89251785 |
| 27 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.85872760 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.66711727 |
| 29 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.66457821 |
| 30 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62900924 |
| 31 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.61591850 |
| 32 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61360164 |
| 33 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.58830530 |
| 34 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.49399610 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48571972 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46915073 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42993610 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.42785081 |
| 39 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.40700463 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.40389418 |
| 41 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37504332 |
| 42 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33568815 |
| 43 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.32077038 |
| 44 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30121385 |
| 45 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29885756 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28835008 |
| 47 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.27613337 |
| 48 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.27366912 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24032297 |
| 50 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.23411084 |
| 51 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18634548 |
| 52 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18516963 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18119970 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17740833 |
| 55 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16823858 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16225790 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13878499 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12222720 |
| 59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11093036 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10754505 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10153785 |
| 62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.09623201 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09387610 |
| 64 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09101710 |
| 65 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06460384 |
| 66 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.06121034 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05221648 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04384989 |
| 69 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.04357525 |
| 70 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04242113 |
| 71 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.04082833 |
| 72 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03622486 |
| 73 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02448351 |
| 74 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.01477911 |
| 75 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.01161261 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01020851 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00928269 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00678306 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00607410 |
| 80 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00539288 |
| 81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99049769 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98712599 |
| 83 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96172040 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95866208 |
| 85 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94623200 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88117760 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88026220 |
| 88 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.87953108 |
| 89 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86583715 |
| 90 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86583715 |
| 91 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86505832 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.85705708 |
| 93 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.85500639 |
| 94 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.85230181 |
| 95 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.84094856 |
| 96 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.84094856 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.84094856 |
| 98 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.83880766 |
| 99 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.83755230 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82813143 |
| 101 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81711122 |
| 102 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81015511 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79225996 |
| 104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78471043 |
| 105 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77874010 |
| 106 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77869576 |
| 107 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76285517 |
| 108 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.76248992 |
| 109 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.75129610 |
| 110 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.74844918 |
| 111 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.73094976 |
| 112 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.72199466 |
| 113 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71191427 |
| 114 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.69593550 |
| 115 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.69061422 |
| 116 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68767314 |
| 117 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.68242940 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.66196352 |
| 119 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.65930574 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.64620518 |
| 121 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64507122 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63293121 |
| 123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63044985 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62058171 |
| 125 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.61320795 |
| 126 | ATF3_27146783_Chip-Seq_COLON_Human | 0.61175201 |
| 127 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60839146 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.60555884 |
| 129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.60053313 |
| 130 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.56260567 |
| 131 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55152981 |
| 132 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.54111403 |
| 133 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54090392 |
| 134 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52902985 |
| 135 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.52442850 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.51397015 |
| 137 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.50502743 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48761849 |
| 139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.48014781 |
| 140 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.47804879 |
| 141 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.47422918 |
| 142 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.47413514 |
| 143 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.47236808 |
| 144 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.46597870 |
| 145 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.45174542 |
| 146 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45137122 |
| 147 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.44470153 |
| 148 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44118509 |
| 149 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43767836 |
| 150 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.43035940 |
| 151 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.42981675 |
| 152 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.42753666 |
| 153 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.42714412 |
| 154 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.41365776 |
| 155 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.40273436 |
| 156 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.40140118 |
| 157 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.39913972 |
| 158 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.39435502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.10356370 |
| 2 | MP0005360_urolithiasis | 7.39577658 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37061704 |
| 4 | MP0005365_abnormal_bile_salt | 6.04074752 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.90315309 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.87721066 |
| 7 | MP0003252_abnormal_bile_duct | 3.87557844 |
| 8 | MP0003941_abnormal_skin_development | 3.49493076 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.48351726 |
| 10 | MP0009840_abnormal_foam_cell | 3.32158415 |
| 11 | MP0004233_abnormal_muscle_weight | 3.17446988 |
| 12 | MP0005083_abnormal_biliary_tract | 3.16211093 |
| 13 | MP0003646_muscle_fatigue | 2.97922589 |
| 14 | MP0000751_myopathy | 2.66005198 |
| 15 | MP0005332_abnormal_amino_acid | 2.63533341 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.56225779 |
| 17 | MP0003195_calcinosis | 2.53841585 |
| 18 | MP0000749_muscle_degeneration | 2.36617864 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.30462982 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.23046343 |
| 21 | MP0000609_abnormal_liver_physiology | 2.18861526 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 2.17376974 |
| 23 | MP0003693_abnormal_embryo_hatching | 2.14285007 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.11466196 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.10320901 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 2.06217057 |
| 27 | MP0004087_abnormal_muscle_fiber | 2.01740984 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.01257548 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.97105538 |
| 30 | MP0008057_abnormal_DNA_replication | 1.81058854 |
| 31 | MP0000747_muscle_weakness | 1.80272374 |
| 32 | MP0003868_abnormal_feces_composition | 1.79567872 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.78550144 |
| 34 | MP0006138_congestive_heart_failure | 1.73754269 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.72076788 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.69140656 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.68243885 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.67071017 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.65022361 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.59294162 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.56973253 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.53429526 |
| 43 | MP0001764_abnormal_homeostasis | 1.53085158 |
| 44 | MP0000759_abnormal_skeletal_muscle | 1.52797506 |
| 45 | MP0005369_muscle_phenotype | 1.49201558 |
| 46 | MP0005330_cardiomyopathy | 1.47791497 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.47261052 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.43850647 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.41928716 |
| 50 | MP0009697_abnormal_copulation | 1.41843606 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.41700212 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.41582131 |
| 53 | MP0003136_yellow_coat_color | 1.39255646 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.37454344 |
| 55 | MP0010630_abnormal_cardiac_muscle | 1.33149236 |
| 56 | MP0005620_abnormal_muscle_contractility | 1.32470882 |
| 57 | MP0000598_abnormal_liver_morphology | 1.28273880 |
| 58 | MP0003011_delayed_dark_adaptation | 1.27338369 |
| 59 | MP0003186_abnormal_redox_activity | 1.27306647 |
| 60 | MP0005171_absent_coat_pigmentation | 1.25161535 |
| 61 | MP0008932_abnormal_embryonic_tissue | 1.24636670 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.24327177 |
| 63 | MP0000383_abnormal_hair_follicle | 1.24223915 |
| 64 | MP0004215_abnormal_myocardial_fiber | 1.22474365 |
| 65 | MP0003077_abnormal_cell_cycle | 1.21425328 |
| 66 | MP0005187_abnormal_penis_morphology | 1.19374298 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 1.19219206 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.17784253 |
| 69 | MP0002009_preneoplasia | 1.16846123 |
| 70 | MP0000537_abnormal_urethra_morphology | 1.14625987 |
| 71 | MP0009703_decreased_birth_body | 1.14073182 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.12910129 |
| 73 | MP0002108_abnormal_muscle_morphology | 1.12553220 |
| 74 | MP0002254_reproductive_system_inflammat | 1.11789563 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.11604216 |
| 76 | MP0000733_abnormal_muscle_development | 1.09338751 |
| 77 | MP0005380_embryogenesis_phenotype | 1.09161535 |
| 78 | MP0001672_abnormal_embryogenesis/_devel | 1.09161535 |
| 79 | MP0005647_abnormal_sex_gland | 1.08550626 |
| 80 | MP0001730_embryonic_growth_arrest | 1.07752687 |
| 81 | MP0005451_abnormal_body_composition | 1.07429819 |
| 82 | MP0003984_embryonic_growth_retardation | 1.03435035 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 1.03210020 |
| 84 | MP0001727_abnormal_embryo_implantation | 1.01051651 |
| 85 | MP0009053_abnormal_anal_canal | 1.00521319 |
| 86 | MP0002697_abnormal_eye_size | 0.99119896 |
| 87 | * MP0009763_increased_sensitivity_to | 0.98288060 |
| 88 | MP0004484_altered_response_of | 0.97940303 |
| 89 | MP0000604_amyloidosis | 0.96086108 |
| 90 | MP0008995_early_reproductive_senescence | 0.95194894 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.89924429 |
| 92 | MP0005385_cardiovascular_system_phenoty | 0.89347384 |
| 93 | MP0001544_abnormal_cardiovascular_syste | 0.89347384 |
| 94 | MP0000647_abnormal_sebaceous_gland | 0.87461601 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.86133207 |
| 96 | MP0001293_anophthalmia | 0.85902730 |
| 97 | MP0008007_abnormal_cellular_replicative | 0.84195396 |
| 98 | MP0005266_abnormal_metabolism | 0.84122625 |
| 99 | MP0005376_homeostasis/metabolism_phenot | 0.83859445 |
| 100 | MP0001697_abnormal_embryo_size | 0.81573437 |
| 101 | MP0009764_decreased_sensitivity_to | 0.81058557 |
| 102 | MP0000377_abnormal_hair_follicle | 0.79448544 |
| 103 | MP0003123_paternal_imprinting | 0.79387603 |
| 104 | MP0002796_impaired_skin_barrier | 0.78796643 |
| 105 | MP0010368_abnormal_lymphatic_system | 0.77621167 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.76761486 |
| 107 | MP0005670_abnormal_white_adipose | 0.75268743 |
| 108 | MP0002080_prenatal_lethality | 0.74706383 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.74340516 |
| 110 | * MP0009642_abnormal_blood_homeostasis | 0.74219799 |
| 111 | MP0005375_adipose_tissue_phenotype | 0.73487440 |
| 112 | MP0005408_hypopigmentation | 0.73396951 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.72812342 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.71864257 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.70951311 |
| 116 | MP0004381_abnormal_hair_follicle | 0.70768889 |
| 117 | MP0003699_abnormal_female_reproductive | 0.70759678 |
| 118 | MP0001661_extended_life_span | 0.70443983 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.69970765 |
| 120 | MP0001340_abnormal_eyelid_morphology | 0.69375392 |
| 121 | MP0008469_abnormal_protein_level | 0.69202900 |
| 122 | MP0003718_maternal_effect | 0.68262179 |
| 123 | MP0002084_abnormal_developmental_patter | 0.68188372 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.67803600 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.67670636 |
| 126 | MP0002085_abnormal_embryonic_tissue | 0.67417280 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.66503283 |
| 128 | * MP0002078_abnormal_glucose_homeostasis | 0.63299068 |
| 129 | MP0002971_abnormal_brown_adipose | 0.63276591 |
| 130 | MP0005334_abnormal_fat_pad | 0.57534578 |
| 131 | MP0005395_other_phenotype | 0.57432704 |
| 132 | MP0004130_abnormal_muscle_cell | 0.55101074 |
| 133 | MP0009672_abnormal_birth_weight | 0.54841502 |
| 134 | MP0003453_abnormal_keratinocyte_physiol | 0.54272231 |
| 135 | MP0004264_abnormal_extraembryonic_tissu | 0.52813857 |
| 136 | MP0003329_amyloid_beta_deposits | 0.51757006 |
| 137 | MP0005023_abnormal_wound_healing | 0.51539965 |
| 138 | MP0001915_intracranial_hemorrhage | 0.50735153 |
| 139 | MP0000639_abnormal_adrenal_gland | 0.50095408 |
| 140 | MP0001756_abnormal_urination | 0.49899964 |
| 141 | MP0001243_abnormal_dermal_layer | 0.49519938 |
| 142 | MP0002060_abnormal_skin_morphology | 0.48979933 |
| 143 | MP0008873_increased_physiological_sensi | 0.48685951 |
| 144 | MP0005248_abnormal_Harderian_gland | 0.48400311 |
| 145 | MP0005448_abnormal_energy_balance | 0.46715041 |
| 146 | MP0005666_abnormal_adipose_tissue | 0.45912660 |
| 147 | MP0010352_gastrointestinal_tract_polyps | 0.45870244 |
| 148 | MP0009384_cardiac_valve_regurgitation | 0.44270725 |
| 149 | MP0005501_abnormal_skin_physiology | 0.42839831 |
| 150 | MP0002928_abnormal_bile_duct | 0.41351148 |
| 151 | MP0002136_abnormal_kidney_physiology | 0.40897507 |
| 152 | MP0003638_abnormal_response/metabolism_ | 0.36528700 |
| 153 | MP0005535_abnormal_body_temperature | 0.36099287 |
| 154 | MP0003690_abnormal_glial_cell | 0.35678768 |
| 155 | MP0002970_abnormal_white_adipose | 0.35340488 |
| 156 | MP0003436_decreased_susceptibility_to | 0.34938018 |
| 157 | MP0002876_abnormal_thyroid_physiology | 0.34594396 |
| 158 | MP0009115_abnormal_fat_cell | 0.34201898 |
| 159 | MP0002269_muscular_atrophy | 0.33617418 |
| 160 | MP0000427_abnormal_hair_cycle | 0.33202262 |
| 161 | MP0003890_abnormal_embryonic-extraembry | 0.32549608 |
| 162 | MP0000579_abnormal_nail_morphology | 0.32260805 |
| 163 | MP0005464_abnormal_platelet_physiology | 0.31832392 |
| 164 | MP0002168_other_aberrant_phenotype | 0.30952087 |
| 165 | MP0001881_abnormal_mammary_gland | 0.30343920 |
| 166 | MP0008874_decreased_physiological_sensi | 0.29642907 |
| 167 | MP0009931_abnormal_skin_appearance | 0.29041336 |
| 168 | MP0001853_heart_inflammation | 0.28831259 |
| 169 | * MP0003953_abnormal_hormone_level | 0.26918952 |
| 170 | MP0002086_abnormal_extraembryonic_tissu | 0.26792335 |
| 171 | MP0004197_abnormal_fetal_growth/weight/ | 0.26753595 |
| 172 | MP0003566_abnormal_cell_adhesion | 0.26717083 |
| 173 | MP0008872_abnormal_physiological_respon | 0.26599897 |
| 174 | MP0004782_abnormal_surfactant_physiolog | 0.26562552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.61638549 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.45083191 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.21904007 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.00775600 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 6.87598630 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.62735328 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.57916492 |
| 8 | Xanthomatosis (HP:0000991) | 6.39111304 |
| 9 | Nemaline bodies (HP:0003798) | 6.36140806 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 6.24229850 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.41022752 |
| 12 | Complement deficiency (HP:0004431) | 5.31372827 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 5.29374534 |
| 14 | Exercise-induced myalgia (HP:0003738) | 5.04647018 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.90771986 |
| 16 | Epidermoid cyst (HP:0200040) | 4.61266135 |
| 17 | Hyperammonemia (HP:0001987) | 4.58679503 |
| 18 | Hyperglycinemia (HP:0002154) | 4.52241528 |
| 19 | Joint hemorrhage (HP:0005261) | 4.51333641 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46218073 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.44873673 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.40392951 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.39318696 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.25070815 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.23366126 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.16819526 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16146613 |
| 28 | Fat malabsorption (HP:0002630) | 4.15703811 |
| 29 | Type 1 muscle fiber predominance (HP:0003803) | 4.08317106 |
| 30 | Abnormality of complement system (HP:0005339) | 4.03393124 |
| 31 | Ketosis (HP:0001946) | 4.01708999 |
| 32 | Hyperglycinuria (HP:0003108) | 3.93428371 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.92403434 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92403434 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.78143699 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71599860 |
| 37 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.64856276 |
| 38 | Abnormality of the calf musculature (HP:0001430) | 3.62664613 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.62442935 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 3.55582927 |
| 41 | Calf muscle hypertrophy (HP:0008981) | 3.46599355 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42631847 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 3.36511591 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 3.32957661 |
| 45 | Muscle fiber splitting (HP:0003555) | 3.25066664 |
| 46 | Rimmed vacuoles (HP:0003805) | 3.22625438 |
| 47 | Hyperbilirubinemia (HP:0002904) | 3.21834583 |
| 48 | Papillary thyroid carcinoma (HP:0002895) | 3.19117136 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 3.15751853 |
| 50 | Steatorrhea (HP:0002570) | 3.10829494 |
| 51 | Skin nodule (HP:0200036) | 3.10314578 |
| 52 | Distal lower limb muscle weakness (HP:0009053) | 3.10047404 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07951396 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 3.05735022 |
| 55 | Myocardial infarction (HP:0001658) | 3.04843601 |
| 56 | Spastic diplegia (HP:0001264) | 3.04321839 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.02389261 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.99639341 |
| 59 | Delayed CNS myelination (HP:0002188) | 2.98857590 |
| 60 | Myoglobinuria (HP:0002913) | 2.98243552 |
| 61 | Neck muscle weakness (HP:0000467) | 2.96756352 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.88071769 |
| 63 | Subaortic stenosis (HP:0001682) | 2.88071769 |
| 64 | Spontaneous abortion (HP:0005268) | 2.82064361 |
| 65 | Myopathic facies (HP:0002058) | 2.80488652 |
| 66 | Asymmetry of the thorax (HP:0001555) | 2.71337712 |
| 67 | Ketoacidosis (HP:0001993) | 2.70492682 |
| 68 | Malignant hyperthermia (HP:0002047) | 2.67851464 |
| 69 | Distal arthrogryposis (HP:0005684) | 2.66876599 |
| 70 | Rhabdomyolysis (HP:0003201) | 2.66123250 |
| 71 | Acanthocytosis (HP:0001927) | 2.64614234 |
| 72 | Bundle branch block (HP:0011710) | 2.63847994 |
| 73 | Microglossia (HP:0000171) | 2.53463881 |
| 74 | Vascular calcification (HP:0004934) | 2.53184380 |
| 75 | Metabolic acidosis (HP:0001942) | 2.53139952 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.51560642 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 2.49391686 |
| 78 | Cholelithiasis (HP:0001081) | 2.48552261 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.48270435 |
| 80 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.46863605 |
| 81 | Lethargy (HP:0001254) | 2.46515764 |
| 82 | Esophageal varix (HP:0002040) | 2.45413975 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.45053299 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.44838252 |
| 85 | Malnutrition (HP:0004395) | 2.42971446 |
| 86 | Cholecystitis (HP:0001082) | 2.40650437 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.40650437 |
| 88 | Chromsome breakage (HP:0040012) | 2.36834782 |
| 89 | Areflexia of lower limbs (HP:0002522) | 2.34481964 |
| 90 | Dysmetric saccades (HP:0000641) | 2.34057895 |
| 91 | Progressive muscle weakness (HP:0003323) | 2.32876304 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.31751252 |
| 93 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31751252 |
| 94 | Gout (HP:0001997) | 2.31190052 |
| 95 | Neonatal onset (HP:0003623) | 2.30671329 |
| 96 | Irritability (HP:0000737) | 2.30633016 |
| 97 | Absent eyebrow (HP:0002223) | 2.30273132 |
| 98 | Cardiovascular calcification (HP:0011915) | 2.29813723 |
| 99 | Glomerulonephritis (HP:0000099) | 2.28063893 |
| 100 | Shoulder girdle muscle weakness (HP:0003547) | 2.26102788 |
| 101 | Right ventricular cardiomyopathy (HP:0011663) | 2.23932846 |
| 102 | Difficulty running (HP:0009046) | 2.22608956 |
| 103 | Thyroid carcinoma (HP:0002890) | 2.20729349 |
| 104 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.19825108 |
| 105 | Distal lower limb amyotrophy (HP:0008944) | 2.19709637 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.17249130 |
| 107 | Mitral stenosis (HP:0001718) | 2.16153046 |
| 108 | Muscle stiffness (HP:0003552) | 2.15396085 |
| 109 | EMG: neuropathic changes (HP:0003445) | 2.14423512 |
| 110 | Increased connective tissue (HP:0009025) | 2.14203296 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 2.13805492 |
| 112 | Cerebral edema (HP:0002181) | 2.13227202 |
| 113 | Absent eyelashes (HP:0000561) | 2.12067515 |
| 114 | Insidious onset (HP:0003587) | 2.12049195 |
| 115 | Termporal pattern (HP:0011008) | 2.12049195 |
| 116 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.11219152 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09612016 |
| 118 | Abnormal cartilage morphology (HP:0002763) | 2.09294745 |
| 119 | Poikilocytosis (HP:0004447) | 2.08160891 |
| 120 | Rickets (HP:0002748) | 2.07625250 |
| 121 | Hemorrhage of the eye (HP:0011885) | 2.03888938 |
| 122 | Hypopigmentation of the fundus (HP:0007894) | 2.03711167 |
| 123 | Pelvic girdle muscle weakness (HP:0003749) | 2.03033174 |
| 124 | Reticulocytosis (HP:0001923) | 2.01905010 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 2.00376790 |
| 126 | Thrombophlebitis (HP:0004418) | 2.00279816 |
| 127 | Menorrhagia (HP:0000132) | 2.00212850 |
| 128 | Embryonal renal neoplasm (HP:0011794) | 1.98834289 |
| 129 | Sensorimotor neuropathy (HP:0007141) | 1.98299558 |
| 130 | Pseudobulbar signs (HP:0002200) | 1.98058558 |
| 131 | Gingival bleeding (HP:0000225) | 1.97355309 |
| 132 | Pancreatitis (HP:0001733) | 1.96163460 |
| 133 | Septate vagina (HP:0001153) | 1.94801877 |
| 134 | Abnormality of the Achilles tendon (HP:0005109) | 1.94417802 |
| 135 | Sudden death (HP:0001699) | 1.93497366 |
| 136 | Choanal stenosis (HP:0000452) | 1.93339286 |
| 137 | Calcaneovalgus deformity (HP:0001848) | 1.93010113 |
| 138 | Asymmetric septal hypertrophy (HP:0001670) | 1.91601273 |
| 139 | Brushfield spots (HP:0001088) | 1.91336022 |
| 140 | Opisthotonus (HP:0002179) | 1.91323017 |
| 141 | Round ear (HP:0100830) | 1.91302827 |
| 142 | Hydroxyprolinuria (HP:0003080) | 1.90282673 |
| 143 | Abnormality of proline metabolism (HP:0010907) | 1.90282673 |
| 144 | Late onset (HP:0003584) | 1.90222030 |
| 145 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89383251 |
| 146 | Back pain (HP:0003418) | 1.87824547 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.87778016 |
| 148 | Upper motor neuron abnormality (HP:0002127) | 1.86965111 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85405169 |
| 150 | Increased mean platelet volume (HP:0011877) | 1.85353824 |
| 151 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84968426 |
| 152 | Abnormality of glycolysis (HP:0004366) | 1.84291114 |
| 153 | Dilated cardiomyopathy (HP:0001644) | 1.84210586 |
| 154 | Amyloidosis (HP:0011034) | 1.83623034 |
| 155 | Abnormality of vitamin metabolism (HP:0100508) | 1.82019713 |
| 156 | Status epilepticus (HP:0002133) | 1.81463449 |
| 157 | Bifid tongue (HP:0010297) | 1.81407325 |
| 158 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.81274286 |
| 159 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.81274286 |
| 160 | Vomiting (HP:0002013) | 1.81105140 |
| 161 | Enlarged kidneys (HP:0000105) | 1.80515191 |
| 162 | Clitoromegaly (HP:0000057) | 1.80243676 |
| 163 | Increased serum pyruvate (HP:0003542) | 1.79970232 |
| 164 | White forelock (HP:0002211) | 1.78928475 |
| 165 | Hypophosphatemic rickets (HP:0004912) | 1.77794564 |
| 166 | Limb-girdle muscle atrophy (HP:0003797) | 1.77087430 |
| 167 | Proximal tubulopathy (HP:0000114) | 1.73267593 |
| 168 | Ulnar deviation of the wrist (HP:0003049) | 1.72466730 |
| 169 | Multiple enchondromatosis (HP:0005701) | 1.71804081 |
| 170 | Frequent falls (HP:0002359) | 1.70375696 |
| 171 | Abnormal lung lobation (HP:0002101) | 1.70190131 |
| 172 | Proximal amyotrophy (HP:0007126) | 1.69449687 |
| 173 | Long clavicles (HP:0000890) | 1.69267321 |
| 174 | Deformed tarsal bones (HP:0008119) | 1.67896029 |
| 175 | Lip pit (HP:0100267) | 1.66004133 |
| 176 | Bicornuate uterus (HP:0000813) | 1.64411745 |
| 177 | Lower limb amyotrophy (HP:0007210) | 1.63683688 |
| 178 | Progressive external ophthalmoplegia (HP:0000590) | 1.63379866 |
| 179 | Patchy hypopigmentation of hair (HP:0011365) | 1.63153235 |
| 180 | Midline defect of the nose (HP:0004122) | 1.62996125 |
| 181 | Heart block (HP:0012722) | 1.61062109 |
| 182 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.60860861 |
| 183 | Breast carcinoma (HP:0003002) | 1.59349412 |
| 184 | Breech presentation (HP:0001623) | 1.58616949 |
| 185 | Abnormal atrioventricular conduction (HP:0005150) | 1.57680910 |
| 186 | Abnormality of the lacrimal duct (HP:0011481) | 1.56585286 |
| 187 | Gowers sign (HP:0003391) | 1.56144170 |
| 188 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.55613204 |
| 189 | Gonadotropin excess (HP:0000837) | 1.55579438 |
| 190 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.54697399 |
| 191 | Myelomeningocele (HP:0002475) | 1.52345578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.77410252 |
| 2 | OBSCN | 5.31096471 |
| 3 | SIK1 | 3.88461443 |
| 4 | FGFR4 | 3.76452425 |
| 5 | ERN1 | 3.64226821 |
| 6 | ERBB4 | 3.24094584 |
| 7 | PKN2 | 3.13685759 |
| 8 | EIF2AK3 | 2.83405378 |
| 9 | EPHA2 | 2.80669548 |
| 10 | TTN | 2.74134325 |
| 11 | LATS1 | 2.43804854 |
| 12 | FLT3 | 2.25567316 |
| 13 | PHKG2 | 2.14182160 |
| 14 | PHKG1 | 2.14182160 |
| 15 | CDK12 | 2.10616175 |
| 16 | BRSK2 | 2.05454585 |
| 17 | TSSK6 | 1.98989672 |
| 18 | MAP3K13 | 1.97111444 |
| 19 | MAP2K4 | 1.90870705 |
| 20 | TRIB3 | 1.86697644 |
| 21 | INSRR | 1.82743854 |
| 22 | BUB1 | 1.79128330 |
| 23 | DMPK | 1.76803299 |
| 24 | TAOK3 | 1.75405242 |
| 25 | MAPK11 | 1.73021038 |
| 26 | PBK | 1.70711588 |
| 27 | NEK1 | 1.70030549 |
| 28 | SRPK1 | 1.69645405 |
| 29 | PTK6 | 1.63374417 |
| 30 | ERBB3 | 1.57169255 |
| 31 | MST1R | 1.56812292 |
| 32 | NEK6 | 1.55880286 |
| 33 | CDK6 | 1.55866478 |
| 34 | STK38L | 1.37844409 |
| 35 | MAP3K11 | 1.33275580 |
| 36 | MAP3K3 | 1.32836932 |
| 37 | LATS2 | 1.30348068 |
| 38 | PIK3CG | 1.30094558 |
| 39 | TIE1 | 1.29420634 |
| 40 | ICK | 1.26846476 |
| 41 | MAP3K10 | 1.25382072 |
| 42 | MET | 1.24628355 |
| 43 | PIK3CA | 1.24012011 |
| 44 | NEK9 | 1.23317623 |
| 45 | MKNK2 | 1.21941582 |
| 46 | ABL2 | 1.19731711 |
| 47 | STK24 | 1.17062334 |
| 48 | MAP2K3 | 1.15984205 |
| 49 | BRD4 | 1.15516739 |
| 50 | BMX | 1.10946087 |
| 51 | CDK4 | 1.09760060 |
| 52 | CDC7 | 1.09046470 |
| 53 | TYK2 | 1.06403556 |
| 54 | MKNK1 | 1.04741257 |
| 55 | MST4 | 1.03265320 |
| 56 | MTOR | 1.03061717 |
| 57 | NME1 | 1.01511926 |
| 58 | FRK | 1.01195326 |
| 59 | KDR | 1.01135953 |
| 60 | CAMK1D | 1.01016552 |
| 61 | TTK | 0.98512906 |
| 62 | MAP3K7 | 0.97927031 |
| 63 | MUSK | 0.97055971 |
| 64 | RPS6KB2 | 0.96974201 |
| 65 | PLK3 | 0.92249380 |
| 66 | FGFR2 | 0.91620846 |
| 67 | STK39 | 0.91206787 |
| 68 | PLK1 | 0.90258500 |
| 69 | DYRK1B | 0.89441386 |
| 70 | RIPK1 | 0.87993525 |
| 71 | PTK2 | 0.87664634 |
| 72 | PDK3 | 0.87449010 |
| 73 | PDK4 | 0.87449010 |
| 74 | ERBB2 | 0.85567133 |
| 75 | TRIM28 | 0.84790903 |
| 76 | GRK6 | 0.84046599 |
| 77 | EIF2AK2 | 0.83414543 |
| 78 | MAPKAPK3 | 0.81422772 |
| 79 | JAK2 | 0.80549928 |
| 80 | RAF1 | 0.79424553 |
| 81 | PRKAA2 | 0.75032529 |
| 82 | MAP3K5 | 0.73405886 |
| 83 | DYRK3 | 0.72981547 |
| 84 | DAPK2 | 0.72135956 |
| 85 | RPS6KB1 | 0.69713031 |
| 86 | SCYL2 | 0.69286189 |
| 87 | EEF2K | 0.69230882 |
| 88 | MAP3K9 | 0.68682527 |
| 89 | TAOK2 | 0.67752379 |
| 90 | WEE1 | 0.67063321 |
| 91 | TRPM7 | 0.66839829 |
| 92 | GSK3A | 0.66725448 |
| 93 | PAK4 | 0.66366991 |
| 94 | EIF2AK1 | 0.65110943 |
| 95 | MAPK4 | 0.62865178 |
| 96 | STK3 | 0.61875635 |
| 97 | ATR | 0.61615957 |
| 98 | AKT3 | 0.61254424 |
| 99 | RPS6KA4 | 0.60081677 |
| 100 | MAP3K8 | 0.58341745 |
| 101 | FGFR1 | 0.57272519 |
| 102 | CLK1 | 0.55868342 |
| 103 | PRKCZ | 0.55468634 |
| 104 | CHUK | 0.55375198 |
| 105 | CHEK1 | 0.55361962 |
| 106 | CDK1 | 0.52717971 |
| 107 | MAPK10 | 0.52154248 |
| 108 | NUAK1 | 0.50976031 |
| 109 | PRKACG | 0.50690906 |
| 110 | PDGFRA | 0.50332602 |
| 111 | TESK2 | 0.50306453 |
| 112 | CDK7 | 0.50000196 |
| 113 | PLK4 | 0.49521626 |
| 114 | ATM | 0.48776411 |
| 115 | PIM1 | 0.47775089 |
| 116 | CSK | 0.47069924 |
| 117 | CDK9 | 0.45517191 |
| 118 | CSNK1E | 0.45475879 |
| 119 | PRKAA1 | 0.45433876 |
| 120 | YES1 | 0.44212785 |
| 121 | NEK2 | 0.43999397 |
| 122 | RPS6KA1 | 0.43995174 |
| 123 | ZAK | 0.43847706 |
| 124 | IRAK3 | 0.43845369 |
| 125 | MAP2K1 | 0.43563809 |
| 126 | MAPK12 | 0.42127969 |
| 127 | BRAF | 0.42035491 |
| 128 | MAP3K14 | 0.40798011 |
| 129 | CHEK2 | 0.40714818 |
| 130 | EGFR | 0.40613993 |
| 131 | BCR | 0.40304255 |
| 132 | PINK1 | 0.39151960 |
| 133 | CDK2 | 0.38655635 |
| 134 | PAK2 | 0.37454129 |
| 135 | FER | 0.36948323 |
| 136 | MAPK15 | 0.35566193 |
| 137 | MAPK7 | 0.35495748 |
| 138 | AKT2 | 0.35287144 |
| 139 | MAP3K12 | 0.35252762 |
| 140 | CAMK2D | 0.34711877 |
| 141 | CSNK1D | 0.33858023 |
| 142 | MAP2K2 | 0.33699124 |
| 143 | CAMK2G | 0.33658765 |
| 144 | ACVR1B | 0.33222965 |
| 145 | AURKA | 0.33126869 |
| 146 | TGFBR1 | 0.32944111 |
| 147 | PDK2 | 0.32712431 |
| 148 | GSK3B | 0.32375748 |
| 149 | PRKCI | 0.32111658 |
| 150 | MAP3K6 | 0.31681107 |
| 151 | JAK1 | 0.31483896 |
| 152 | STK10 | 0.31459440 |
| 153 | RET | 0.30658644 |
| 154 | AURKB | 0.30299591 |
| 155 | TBK1 | 0.30284683 |
| 156 | PRKCG | 0.29350850 |
| 157 | PAK3 | 0.28520732 |
| 158 | IGF1R | 0.28064332 |
| 159 | GRK1 | 0.25329678 |
| 160 | MAP2K6 | 0.25216649 |
| 161 | CSNK2A2 | 0.25186515 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44151519 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.86344980 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.56139706 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31609561 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13252577 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.73863222 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73047668 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62139683 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61256610 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54535217 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38833395 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26903163 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 2.22563806 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19168308 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02271448 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96104383 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.94356403 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.92961315 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90091417 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88653850 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86542005 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82949727 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82031436 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80489542 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78557875 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.77027730 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76072452 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73430281 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72318997 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65913297 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64198900 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61894782 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56345491 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55699959 |
| 35 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.53707675 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.51843522 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49026584 |
| 38 | RNA transport_Homo sapiens_hsa03013 | 1.45907329 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.45597526 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45313212 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44021493 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41783855 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37131105 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32932096 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32676235 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28040033 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26864557 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25276833 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.24465710 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23059285 |
| 51 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21599863 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20423861 |
| 53 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.19957847 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19611082 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19377222 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19209406 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.14018955 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12995325 |
| 59 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11473058 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09287583 |
| 61 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.05987748 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05232571 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 1.02819712 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.99561052 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99380027 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96650657 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.93181332 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92428462 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.92040247 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.90653963 |
| 71 | Mismatch repair_Homo sapiens_hsa03430 | 0.89577269 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.87316838 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82796815 |
| 74 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82408115 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81897187 |
| 76 | RNA degradation_Homo sapiens_hsa03018 | 0.81453973 |
| 77 | Base excision repair_Homo sapiens_hsa03410 | 0.79956988 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77586987 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73640629 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.72658738 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72062404 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71184310 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70877996 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.66688655 |
| 85 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63771228 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62706304 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57881478 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54321617 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54154359 |
| 90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54131594 |
| 91 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52252374 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.49374828 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47546942 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47337650 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46543570 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46286667 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44919198 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44757967 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.44525781 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44480075 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43539088 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41351055 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.39418626 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36908367 |
| 105 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35833236 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35169749 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28530464 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.21656600 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19475996 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18773620 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16157369 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12284852 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12144068 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11935928 |
| 115 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.11177305 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07711705 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06777115 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.05823418 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.02014593 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2248696 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2219022 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2098403 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2071979 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | -0.2017118 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.1978486 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1945754 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | -0.1926811 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1802861 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1398721 |
| 130 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1308182 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1252240 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0946758 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0891104 |
| 134 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0525405 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0231497 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0069857 |

